Effects of PPAR [peroxisome proliferator-activated receptor] ligands on ectopic fat accumulation and inflammation in subjects with impaired glucose tolerance.
Phase of Trial: Phase III
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Fenofibrate (Primary) ; Pioglitazone (Primary)
- Indications Insulin resistance; Obesity
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 09 Jun 2016 Status changed from active, no longer recruiting to completed.
- 23 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014, according to ClinicalTrials.gov record.